EP0711572A1 — Inhalation medicator and method of using the same
Assigned to Dott Co Ltd · Expires 1996-05-15 · 30y expired
What this patent protects
A suction piece (1) is provided with an inhaling port (3) and a holder housing member (2). A capsule holder (6) is provided with a capsule housing bore (7), axially extending ventilation passages (8, 8), and pin insert holes (10, 11) communicating with these ventilation passages …
USPTO Abstract
A suction piece (1) is provided with an inhaling port (3) and a holder housing member (2). A capsule holder (6) is provided with a capsule housing bore (7), axially extending ventilation passages (8, 8), and pin insert holes (10, 11) communicating with these ventilation passages (8) and extending in the radial direction. When a capsule (17) is held in the capsule housing bore (7) with pins (16) inserted in the pin insert holes (10, 11), through bores (H, H, ...) are formed in the capsule (17). When a patient inhales medicine with the pins (16) of a boring unit (14) returned to the suction piece (1), the medicine can be transferred to the lungs of the patient reliably and efficiently owing to the air current.
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.